Compare RLAY & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | CALM |
|---|---|---|
| Founded | 2015 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.1B |
| IPO Year | 2020 | 1996 |
| Metric | RLAY | CALM |
|---|---|---|
| Price | $18.33 | $63.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 4 |
| Target Price | $27.58 | ★ $68.33 |
| AVG Volume (30 Days) | ★ 2.5M | 1.3M |
| Earning Date | 11-05-2026 | 09-30-2026 |
| Dividend Yield | N/A | ★ 4.05% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,355,000.00 | ★ $2,911,632,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $60.51 | $12.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $5.95 | $60.13 |
| 52 Week High | $21.27 | $95.25 |
| Indicator | RLAY | CALM |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 40.10 |
| Support Level | $17.67 | $61.88 |
| Resistance Level | $20.09 | $80.00 |
| Average True Range (ATR) | 0.97 | 2.12 |
| MACD | 0.10 | 0.30 |
| Stochastic Oscillator | 65.28 | 58.18 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs. The Company operates through the Conventional Shell Eggs, Specialty Shell Eggs and Prepared Foods segments, with Conventional Shell Eggs generating maximum revenue. The Conventional Shell Eggs segment consists mainly of the production, grading, packaging, marketing and distribution of conventional shell eggs, including Sunups and Sunny Meadow. The Company sells its products to grocery store chains, club stores, independent supermarkets, and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the U.S.